| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/25/2004 | WO2004024769A2 Ostertagia vaccine |
| 03/25/2004 | WO2004024766A1 Kdr peptides and vaccines containing the same |
| 03/25/2004 | WO2004024764A1 Pharmaceutical composition and medical treatments comprising notch ligand proteins |
| 03/25/2004 | WO2004024756A2 Orthopoxvirus antigens and use thereof |
| 03/25/2004 | WO2004024189A1 Stable immunogenic product comprising antigenic heterocomplexes |
| 03/25/2004 | WO2004024182A2 Method for isolating hepatitis c virus peptides |
| 03/25/2004 | WO2004024181A1 New tumor antigen vaccine and producing method and vaccine composition |
| 03/25/2004 | WO2004024174A1 Method and composition for regulating the activity of regulatory t cells |
| 03/25/2004 | WO2004024129A1 Induced remission therapy |
| 03/25/2004 | WO2004024097A2 Compositions and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024090A2 Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence |
| 03/25/2004 | WO2004024077A2 Novel composition and methods for the treatment of psoriasis |
| 03/25/2004 | WO2004024076A2 Novel compositions and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024075A2 Chemokine receptor antagonists as therapeutic agents |
| 03/25/2004 | WO2004024068A2 Novel composition and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024067A2 Codon-optimized polynucleotide-based vaccines against bacillus anthracis infection |
| 03/25/2004 | WO2004024064A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | WO2004024063A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | WO2004014367A3 Use of an amyloid beta vaccination in combination with a selective cox-2 inhibitor for the treatment of alzheimer's disease |
| 03/25/2004 | WO2004009621A3 Polypeptides of nontypeable haemophilus influenzae |
| 03/25/2004 | WO2004007722A3 Transgenic animal expressing alzheimer’s tau protein |
| 03/25/2004 | WO2004003011A3 Nuclear hormone receptor |
| 03/25/2004 | WO2003105890A3 Vaccine comprising mixtures of multivalent meningococcal outer membrane vesciles |
| 03/25/2004 | WO2003103822A3 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s) |
| 03/25/2004 | WO2003097677A3 Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus |
| 03/25/2004 | WO2003093485A3 Optimization of transgene expression in mammalian cells |
| 03/25/2004 | WO2003092624A3 Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 03/25/2004 | WO2003092610A3 Methods of using cytokine antagonists to treat hiv infection and aids |
| 03/25/2004 | WO2003091401A3 Multi plasmid system for the production of influenza virus |
| 03/25/2004 | WO2003090685A3 Methods for stimulating tlr/irf3 pathways for inducing anti-microbial, anti-inflammatory and anticancer responses |
| 03/25/2004 | WO2003088996A3 Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines |
| 03/25/2004 | WO2003087154A3 Sequences involved in the phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses, and the use of the same as medicaments |
| 03/25/2004 | WO2003083098A3 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol-dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy |
| 03/25/2004 | WO2003082908A3 Use of the p17 protein of hiv in isolated form for the preparation of a medicament for administration to hiv seropositive patients, as well as pharmaceutical compositions comprising said protein |
| 03/25/2004 | WO2003076591A3 Compositions and methods for generating an immune response |
| 03/25/2004 | WO2003075741A9 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 03/25/2004 | WO2003074551A3 Conjugates of therapeutic or cytotoxic agents and biologically active peptides |
| 03/25/2004 | WO2003072044A3 Selection of poultry eimeria strains through extra-intestinal sporozoites |
| 03/25/2004 | WO2003057823A3 Epitope synchronization in antigen presenting cells |
| 03/25/2004 | WO2003045427A3 Pharmaceutical composition for inducing an immune response in a human or animal |
| 03/25/2004 | WO2003042243A3 Immunogenic alk (anaplastic lymphoma kinase) peptides |
| 03/25/2004 | WO2003039475A3 Methods of identifying and using modulators of fractalkine receptor |
| 03/25/2004 | WO2003033680A3 Kinases and phosphatases |
| 03/25/2004 | WO2003031475A3 Antibodies against kdr, their production and uses |
| 03/25/2004 | WO2003020215A3 Methods of treating mycocardial event related coditions with thymosin beta 4 |
| 03/25/2004 | WO2003015812A3 Beta-amyloid-analogue-t-cell epitop vaccine |
| 03/25/2004 | WO2003014731B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 03/25/2004 | WO2003014301A3 Hprp4s as modifiers of the p53 pathway and methods of use |
| 03/25/2004 | WO2003004519A9 Icosahedral superstructures of vp2 of infectious bursitis virus (ibdv) and the applications thereof |
| 03/25/2004 | WO2002102829A3 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 03/25/2004 | WO2002096942A3 Recombinant dna encoding the major allergen of plantago lanceolata pollen pla l 1, and applications thereof |
| 03/25/2004 | WO2002089832A3 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. |
| 03/25/2004 | WO2002085093A3 Replikin peptides and uses thereof |
| 03/25/2004 | WO2002083859A8 Surface proteins of streptococcus pyogenes |
| 03/25/2004 | WO2002074048A3 P-glycoproteins and uses thereof |
| 03/25/2004 | WO2002072832A3 Therapeutic binding molecules |
| 03/25/2004 | WO2002066044A3 Method for dendritic cells based immunotherapy of tumors using combination therapy |
| 03/25/2004 | WO2002044342A3 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 03/25/2004 | WO2002034288A8 Vaccine for treating allergy |
| 03/25/2004 | WO2001092470A3 Dna expression vectors and methods of use |
| 03/25/2004 | US20040059094 Hapten-carrier conjugates and uses thereof |
| 03/25/2004 | US20040059090 Novel compounds |
| 03/25/2004 | US20040058984 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans |
| 03/25/2004 | US20040058863 Genetic engineered polypeptide; influenza vaccine, gramnegative bacteria; induce immunology response |
| 03/25/2004 | US20040058859 Multiple antigen glycopeptide carbohydrate vaccine comprising the same and use thereof |
| 03/25/2004 | US20040058445 Transgenic lymphocyte culture capable of inducing tumor destructive immunological response; immunotherapy |
| 03/25/2004 | US20040058443 Manipulation of non-terminally differentiated cells using the Notch pathway |
| 03/25/2004 | US20040058414 Preparing antibody capable of binding and inhibiting activity of interleukin-2 and receptor, herpes viral epitopes and interferon receptors; diagnosis and treatment of viral and autoimmune diseases |
| 03/25/2004 | US20040058402 Method for purifying the helicobacter adhesin-like protein a (alpa) |
| 03/25/2004 | US20040058398 Pancreatic progenitor cells and methods for isolating the same |
| 03/25/2004 | US20040058394 Humanized anti-LT-beta-R antibodies |
| 03/25/2004 | US20040058342 Comprises serine protease for diagnosis, prognosis and treatment of cell proliferative disorders |
| 03/25/2004 | US20040058319 Comprises nucleotide sequences coding urogenital polypeptide for diagnosis and treatment cancer |
| 03/25/2004 | US20040057969 Compositions containing stabilized hepatitis antigen and methods of their use |
| 03/25/2004 | US20040057968 T cell binding ligand peptides, peptide constructs containing same and use thereof for treatment of immunological disorders |
| 03/25/2004 | US20040057966 RecA mutant mycobacteria, particularly mutants of mycobacterial species which are members of the Mycobacterium tuberculosis complex, such as M.bovis BCG and M.tuberculosis; immunotherapteutic agents, vaccines, for tuberculosis |
| 03/25/2004 | US20040057965 Compositions and methods for treatment of mucosal infections |
| 03/25/2004 | US20040057963 Therapeutic TB vaccine |
| 03/25/2004 | US20040057962 Immunogenic complex |
| 03/25/2004 | US20040057961 Human t cell response to mhc-binding motif clusters |
| 03/25/2004 | US20040057960 Activating hepatitis C virus (HCV)-specific T cells, including CD4+ and CD8+ T cells, using fusion proteins comprising HCV, NS3, NS4, NS5a, and NS5b polypeptides, polynucleotides encoding such fusion proteins; immunogens |
| 03/25/2004 | US20040057958 Immunogenicity-enhancing carriers and compositions thereof and methods of using the same |
| 03/25/2004 | US20040057954 Tumor necrosis factor antagonists and their use in endometriosis |
| 03/25/2004 | US20040057951 Co-administration of a thrombolytic and an anti-CD18 antibody in stroke |
| 03/25/2004 | US20040057948 For use as an anticancer agent and an immunosuppressive agent |
| 03/25/2004 | US20040057935 Intratumoral delivery of dendritic cells |
| 03/25/2004 | US20040057930 Method for the development of an HIV vaccine |
| 03/25/2004 | US20040057929 Administering viruses selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus to mammal having Ras-activated pathway to result in lysis of proliferating cells |
| 03/25/2004 | US20040057928 Use of IL-6R/IL-6 chimera, a mutein, isoform, fused protein, functional derivative, active fraction or circularly permutated derivative or a salt thereof, for manufacture of medicament for therapy and/or prophylaxis |
| 03/25/2004 | US20040057902 For use in diagnosis and therapy |
| 03/25/2004 | DE10242076A1 New covalently bonded conjugates of hydroxyalkyl starch with allergens, useful as modified allergens with depot effect for use in specific immunotherapy for combating allergies, e.g. hay fever |
| 03/25/2004 | CA2499215A1 A method of treating an autoimmune disease |
| 03/25/2004 | CA2499214A1 Stable immunogenic product comprising antigenic heterocomplexes |
| 03/25/2004 | CA2499075A1 Production of bispecific molecules using polyethylene glycol linkers |
| 03/25/2004 | CA2498784A1 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 03/25/2004 | CA2498770A1 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 03/25/2004 | CA2498502A1 Recombinant clostridial toxin fragments with proteolytic activation |
| 03/25/2004 | CA2498407A1 Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence |
| 03/25/2004 | CA2498367A1 Viral deconstruction through capsid assembly in vitro |
| 03/25/2004 | CA2498274A1 Compositions and methods for the diagnosis of immune related diseases using pro7 |